Videos and Podcasts
Watch a recording of the Pharmaxis Ltd September Quarterly Shareholder Update by the chief executive officer Mr Gary Phillips on Thursday 28 October 2021.
Watch recording here.
Pharmaxis CEO Gary Phillips speaks to Proactive Investors following the news the Company has been cleared to progress its bone marrow cancer trial to a phase 2 dose expansion phase. It follows further positive results of data analysis from the phase 1c clinical trial of its drug PXS‐5505.
Watch the interview here.